FMR CORP 13D and 13G filings for Sana Biotechnology, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-12 10:34 am Purchase |
2024-11-08 | 13G | Sana Biotechnology, Inc. SANA |
FMR CORP | 31,609,175 14.208% |
9,441,625 (+42.59%) |
Filing |
| 2024-04-03 09:52 am Purchase |
2024-04-02 | 13G | Sana Biotechnology, Inc. SANA |
FMR CORP | 22,167,550 10.055% |
6,416,259 (+40.73%) |
Filing |
| 2024-02-09 09:49 am Purchase |
2024-02-08 | 13G | Sana Biotechnology, Inc. SANA |
FMR CORP | 15,751,291 7.990% |
6,046,193 (+62.30%) |
Filing |
| 2023-04-26 08:13 am Purchase |
2023-04-26 | 13G | Sana Biotechnology, Inc. SANA |
FMR CORP | 9,705,098 5.071% |
535,688 (+5.84%) |
Filing |
| 2023-02-09 08:14 am Sale |
2023-02-09 | 13G | Sana Biotechnology, Inc. SANA |
FMR CORP | 9,169,410 4.807% |
-323,585 (-3.41%) |
Filing |
| 2022-05-19 08:27 am Purchase |
2022-05-18 | 13G | Sana Biotechnology, Inc. SANA |
FMR CORP | 9,492,995 5.005% |
865,144 (+10.03%) |
Filing |
| 2022-02-09 10:24 am Sale |
2022-02-08 | 13G | Sana Biotechnology, Inc. SANA |
FMR CORP | 8,627,851 4.569% |
-822,410 (-8.70%) |
Filing |
| 2021-02-10 09:23 am Purchase |
2021-02-09 | 13G | Sana Biotechnology, Inc. SANA |
FMR CORP | 9,450,261 5.390% |
9,450,261 (New Position) |
Filing |